How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do?

被引:22
|
作者
Macleod, John [1 ]
Hickman, Matthew [1 ]
机构
[1] Univ Bristol, Dept Social Med, Bristol B58 2PS, Avon, England
基金
英国医学研究理事会;
关键词
Cannabis; evidence; public health; schizophrenia; CORONARY-HEART-DISEASE; STRESSFUL LIFE EVENTS; YOUNG-PEOPLE; PSYCHOTIC SYMPTOMS; ADULT PSYCHOSIS; SCHIZOPHRENIA; RISK; GENE; POPULATION; DEPRESSION;
D O I
10.1111/j.1360-0443.2009.02846.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
In the United Kingdom, as in many places, cannabis use is considered substantially within a criminal justice rather than a public health paradigm with prevention policy embodied in the Misuse of Drugs Act. In 2002 the maximum custodial sentence tariff for cannabis possession under the Act was reduced from 5 to 2 years. Vigorous and vociferous public debate followed this decision, centred principally on the question of whether cannabis use caused schizophrenia. It was suggested that new and compelling evidence supporting this hypothesis had emerged since the re-classification decision was made, meaning that the decision should be reconsidered. The re-classification decision was reversed in 2008. We consider whether the strength of evidence on the psychological harms of cannabis has changed substantially and discuss the factors that may have influenced recent public discourse and policy decisions. We also consider evidence for other harms of cannabis use and public health implications of preventing cannabis use. We conclude that the strongest evidence of a possible causal relation between cannabis use and schizophrenia emerged more than 20 years ago and that the strength of more recent evidence may have been overstated-for a number of possible reasons. We also conclude that cannabis use is almost certainly harmful, mainly because of its intimate relation to tobacco use. The most rational policy on cannabis from a public health perspective would seem to be one able to achieve the benefit of reduced use in the population while minimizing social and other costs of the policy itself. Prohibition, whatever the sentence tariff associated with it, seems unlikely to fulfil these criteria.
引用
收藏
页码:1326 / 1330
页数:5
相关论文
共 50 条
  • [41] HOW DO WE KNOW WHAT WE KNOW AND HOW CAN WE EXTEND WHAT WE KNOW
    ROSENBLOOM, DH
    PUBLIC ADMINISTRATION REVIEW, 1991, 51 (02) : 95 - 96
  • [42] How Do We Know What We Know... and How Do We Show It?
    Dean, Kathy Lund
    Forray, Jeanie M.
    JOURNAL OF MANAGEMENT EDUCATION, 2014, 38 (06) : 779 - 783
  • [43] Working with dreams in therapy: What do we know and what should we do?
    Pesant, N
    Zadra, A
    CLINICAL PSYCHOLOGY REVIEW, 2004, 24 (05) : 489 - 512
  • [44] Genetic consequences of hunting: what do we know and what should we do?
    Harris, RB
    Wall, WA
    Allendorf, FW
    WILDLIFE SOCIETY BULLETIN, 2002, 30 (02): : 634 - 643
  • [45] Multinational monkeypox outbreak: what do we know and what should we do?
    Memariani, Mojtaba
    Memariani, Hamed
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (02) : 721 - 722
  • [46] Multinational monkeypox outbreak: what do we know and what should we do?
    Mojtaba Memariani
    Hamed Memariani
    Irish Journal of Medical Science (1971 -), 2023, 192 : 721 - 722
  • [47] Alcohol and cardiovascular disease; What do we know? What should we do?
    Trevisan, M
    Dorn, J
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1996, 6 (03) : 111 - 113
  • [48] Genetic platforms: Do we do what we know? or do we know what we do?
    Bernet, Laia
    Pla, Maria Jesus
    Janez, Noelia Martinez
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2021, 34 (02): : 100 - 110
  • [49] What do we know about tocolytic effectiveness and how do we use this information in guidelines? A comparison of evidence grading
    Roos, C.
    Borowiack, E.
    Kowalska, M.
    Zapalska, A.
    Mol, B. W.
    Mignini, L.
    Meads, C.
    Walczak, J.
    Khan, K. S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (13) : 1588 - 1598
  • [50] CHOLESTEROL POLICY - WHAT SHOULD WE DO - HOW SHOULD WE DECIDE
    KOTTKE, TE
    BREKKE, ML
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (10) : 1023 - 1027